The lfcs consortium: in vitro dispersion tests are an effective first screen during lipid-based formulation development and evaluation

• In: Posters D - Formulation Design and Pharmaceutical Technology
• At: PSWC, Melbourne (Australia) (2014)
• Type: Poster
• Poster code: PD-067
• By: POUTON, Colin (Monash University, Monash Institute of Pharmaceutical Sciences, Parkville, Australia)
• Co-author(s): Williams, Hywel (Monash University, Parkville, Australia)
  Anby, Mette (Monash University, Parkville, Australia)
  Mcevoy, Claire (Monash University, Parkville, Australia)
  Thomas, Nicky (University of Copenhagen, Copenhagen, Denmark)
  Calderone, Marilyn (Sanofi R&D, Montpellier, France)
  Igonin, Annabel (Capsugel, Illkirch, France)
  Vertommen, Jan (Capsugel, Illkirch, France)
  Blundell, Ross (Sanofi R&D, Montpellier, France)
  Benameur, Hassan (Capsugel, Illkirch, France)
  Mullertz, Anette (University of Copenhagen, Copenhagen, Denmark)
  Porter, Chris (Monash University, Parkville, Australia)
  
• Abstract:

  I. Background: The LFCS Consortium looks to establish standardized in vitro performance tests for lipid-based formulations (LBF).
  II. Aims: Here we evaluate the performance of four LBFs containing danazol (DAN), fenofibrate (FFB), tolfenamic acid (TA) or cinnarizine (CIN) on dispersion using different test conditions.
  III. Methods: Dispersion..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login